ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China flag China · Delayed Price · Currency is CNY
12.71
-1.41 (-9.99%)
Sep 10, 2026, 3:00 PM CST

SHA:600479 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
706.75780.151,3441,9981,240632.88
Short-Term Investments
----18251.94
Trading Asset Securities
1.231.944.76-491.74736.84
Cash & Short-Term Investments
707.98782.081,3491,9981,9141,422
Cash Growth
-17.56%-42.03%-32.47%4.40%34.61%-5.74%
Accounts Receivable
855.56819.27823.34912.54847.17830.93
Other Receivables
103.9118.0121.9228.2627.8331.23
Receivables
959.47837.28845.26940.8875862.16
Inventory
490.95490.35485.94534.14598.99547.78
Prepaid Expenses
---0.240.733.44
Other Current Assets
73.2453.8948.4841.4125.0782.22
Total Current Assets
2,2322,1642,7293,5143,5132,917
Property, Plant & Equipment
614.66606.08561.31589.93547.02630.19
Long-Term Investments
1,7601,812953.32247.61187.59190.77
Goodwill
14.0714.0714.0714.0714.0714.07
Other Intangible Assets
246.39231.77208.22212.21195.11201.9
Long-Term Deferred Tax Assets
25.0322.9416.9722.6719.294.12
Long-Term Deferred Charges
80.7690.4367.4471.7371.4176.98
Other Long-Term Assets
25.9522.686.034.1886.6424.93
Total Assets
4,9984,9644,5564,6774,6354,060

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
701.74702.98565.64647.49780.92511.67
Accrued Expenses
99.05404.26376.14402.93376.04267.41
Short-Term Debt
115.0159.7111.956.6958.1367.09
Current Portion of Long-Term Debt
14.9-753.53
Current Portion of Leases
-13.3213.7816.5617.8418.55
Current Income Taxes Payable
27.717.133.6337.2831.2923.89
Current Unearned Revenue
74.5998.2495.27123.61131.2199.59
Other Current Liabilities
503.81195.47259.43252.27298.3237.22
Total Current Liabilities
1,5371,4911,3331,5421,6971,228
Long-Term Debt
---71215.5
Long-Term Leases
26.1128.5125.9631.4632.7644.79
Long-Term Unearned Revenue
55.9662.1133.6638.0444.4451.27
Pension & Post-Retirement Benefits
-1.91.91.91.91.9
Long-Term Deferred Tax Liabilities
24.1123.8317.6524.7224.0613.22
Other Long-Term Liabilities
7.096.055.195.195.195.19
Total Liabilities
1,6501,6141,4171,6501,8181,360

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
492.21492.21424428.92429.81418.51
Additional Paid-In Capital
941.62941.57603.25631.18635.44585.49
Retained Earnings
1,5871,5931,4501,3631,1921,146
Treasury Stock
---16.56-35.02-41.81-
Comprehensive Income & Other
1.761.761.581.591.40.75
Total Common Equity
3,0223,0282,4622,3902,2172,150
Minority Interest
326.26321.86676.87637.08600.07549.55
Shareholders' Equity
3,3483,3503,1393,0272,8172,700
Total Liabilities & Equity
4,9984,9644,5564,6774,6354,060

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
156.01101.5458.64116.71124.24148.93
Net Cash (Debt)
551.97680.551,2911,8811,7891,273
Net Cash Growth
-30.98%-47.27%-31.39%5.13%40.60%-5.93%
Net Cash Per Share
1.191.583.124.454.183.04
Filing Date Shares Outstanding
492.32492.21424428.92428.12418.51
Total Common Shares Outstanding
492.32492.21424428.92428.12418.51
Working Capital
694.85672.491,3961,9731,8161,689
Book Value Per Share
6.146.155.815.575.185.14
Tangible Book Value
2,7622,7822,2402,1632,0081,934
Tangible Book Value Per Share
5.615.655.285.044.694.62
Buildings
-819.48799.74780.42765.95650.15
Machinery
-531.27491.41485.55395.8436.31
Construction In Progress
-32.4513.356.125.7894.34